CST1 and gastric cancer: In addition, the results of the article by Wang et al. (Wang et al., 2020b) identified that Fibronectin 1 (FN1), COL1A1, Inhibin beta-A (INHBA), and cystatin SN (CST1) might be potential biomarkers and therapeutic targets for GC patients.